Known history or presence of severe acute or chronic liver disease (compensated or decompensated), known cholelithiasis or cholecystitis or bile duct disease, acute or chronic pancreatitis (or medication associated with severe pancreatitis, such as valproate) or severe gastrointestinal dysmotility syndrome, including functional disorders such as severe irritable bowel syndrome
Among GH releasing factors, GH-releasing peptides (GHRPs) are acquiring relevance because of the extension of their suspected misuse
Step 3: Hypothesis Validation and Expert Consultation Market hypotheses developed in previous steps will be validated through a series of interviews and surveys with industry experts, including healthcare practitioners and pharmaceutical executives
10.1016/S0378-4347(00)81869-1
In conducting this review, we followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines to ensure rigorous methodology and transparent presentation of data
Adams JB, Baral M, Geis E, Mitchell J, Ingram J, Hensley A, Zappia I, Newmark S, Gehn E, Rubin RA: The severity of autism is associated with toxic metal body burden and red blood cell glutathione levels
